Company news

Cipher Pharmaceuticals Inc. news in 2025

Cipher Pharmaceuticals Inc.'s news releases, calls and decks from 2025, newest first.

View company

Cipher Pharmaceuticals Reports Third Quarter 2025 Results

November 6, 2025

Cipher Pharmaceuticals Schedules Q3 2025 Earnings Release and Conference Call

October 29, 2025

Cipher Pharmaceuticals Receives Successful Arbitration Award

October 14, 2025

Cipher Pharmaceuticals Announces the Passing of Director Mr. Harold Wolkin

August 26, 2025

Cipher Pharmaceuticals Reports Second Quarter 2025 Results, Including Record Revenue

August 7, 2025

Cipher Pharmaceuticals Schedules Q2 2025 Earnings Release and Conference Call

July 29, 2025

Cipher Pharmaceuticals Announces Results of Annual and Special Meeting of Shareholders

June 13, 2025

Cipher Pharmaceuticals Reports First Quarter 2025 Results, and Announces $15 Million Debt Repayment

May 8, 2025

Cipher Pharmaceuticals Schedules Q1 2025 Earnings Release and Conference Call

May 2, 2025

Cipher Pharmaceuticals Announces Normal Course Issuer Bid, Including Intention to Utilize Block Purchases

May 1, 2025

Cipher Pharmaceuticals Secures Medicaid Step-Through Preferred Status for Natroba™ in the state of Illinois

April 29, 2025

Cipher Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Results

March 18, 2025

Cipher Pharmaceuticals Schedules Q4 & Fiscal 2024 Earnings Release and Conference Call

March 11, 2025

Calls in 2025

Decks in 2025